News

According to the company sources, the new product, an injection formulation of the Juvidex active ingredient M6P will be used in the treatment for tendon adhesions, and the

The company further plans to start a development program to examine the investigational product as an oral treatment for male hypogonadism, also known as low testosterone (low T).

For the third quarter of fiscal 2009, the company reported product revenue of $9,174,000 for the third quarter of fiscal 2009, a 12.7% increase, compared with $8,139,000 in

This crucial phase III clinical trial is designed to evaluate the effectiveness and safety of lubiprostone in Japanese patients with CIC over a 28-day treatment period. This trial

The 13,000 square feet primary and secondary trial packaging unit that expands the active pharmaceutical ingredient (API) site in Morpeth, Humberside, will serve as one stop shop for

The states which are up against Wyeth are California, Delaware, the District of Columbia, Florida, Illinois, Indiana, Louisiana, Massachusetts, Michigan, New Hampshire, New York, Nevada, Tennessee, Texas, Virginia,

WellCare will pay a total civil penalty of $10 million, and $1 for disgorgement, in addition to post-judgment interest. The initial payment of $2.5 million will be paid

The acquisition is subject to clearance under the Hart-Scott-Rodino Antitrust Improvement Act and other customary closing conditions. Cowen and Company is acting as exclusive financial advisor to Victory

Ministry of Health aims to reduce the country’s import bill of $1.8 billion due to 70% of imported pharmaceutical products that was noticed in 2007. It seeks to